xylitol has been researched along with Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blaeser, AR; Branch, EK; Guo, F; Lu, PJ; Lu, QL; Tucker, JD | 1 |
| Aubry, D; Ballestrero, A; Bello, C; Cea, M; Dal Bello, G; Duchosal, MA; Dupuis, M; Fruscione, F; Garuti, A; Grossi, F; Loretan, J; Moran, E; Motta, G; Nahimana, A; Nencioni, A; Patrone, F; Pronzato, P; Sordat, B; Vogel, P; Wartmann, M; Zimmermann, K | 1 |
2 other study(ies) available for xylitol and Breast Cancer
| Article | Year |
|---|---|
Ribitol enhances matriglycan of α-dystroglycan in breast cancer cells without affecting cell growth.
Topics: Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chromatography, Liquid; Dystroglycans; Female; Gene Expression Regulation, Neoplastic; Glycosylation; Humans; Immunohistochemistry; Pentosephosphates; Ribitol; Tandem Mass Spectrometry | 2020 |
Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Female; Humans; Jurkat Cells; Neoplasms; Ribitol; Structure-Activity Relationship | 2011 |